Laurion Capital Management LP Dexcom Inc Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $800,224 - $931,922	7,115 New	7,115 $914,000
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $65,474 - $127,973	-963 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $34,151 - $47,262	363 Added 60.5%	963 $493,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $77,922 - $97,692	600 New	600 $322,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $76,311 - $94,266	-900 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $448,188 - $600,457	-5,746 Reduced 86.46%	900 $333,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $416,571 - $700,089	6,646 New	6,646 $2.69 Million

1,080

351M

8.56M

5.95M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.